AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CMPX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for Compass Therapeutics, Inc. stock after losing 0%
(Updated on May 21, 2024)

Hold candidate since May 20, 2024 PDF

No changes to the price of Compass Therapeutics, Inc. stock on the last trading day (Tuesday, 21st May 2024). During the last trading day the stock fluctuated 6.38% from a day low at $1.52 to a day high of $1.62. The price has risen in 4 of the last 10 days but is still down by -4.76% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.80% during the next 3 months and, with a 90% probability hold a price between $1.03 and $1.48 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CMPX Signals & Forecast

The Compass Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.59 and $1.59. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 11.11%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point".

Support, Risk & Stop-loss for Compass Therapeutics, Inc. stock

Compass Therapeutics, Inc. finds support from accumulated volume at $1.57 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0969 between high and low, or 6.38%. For the last week, the stock has had daily average volatility of 5.52%.

Our recommended stop-loss: $1.54 (-3.94%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 46 days ago.)

Trading Expectations (CMPX) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Compass Therapeutics, Inc. to open at $1.58, and during the day (based on 14 day Average True Range), to move between $1.47 and $1.73, which gives a possible trading interval of +/-$0.126 (+/-7.86%) up or down from last closing price. If Compass Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 15.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.62 (1.25%) than the support at $1.57 (1.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Compass Therapeutics, Inc. stock A Buy?

Compass Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.292 Hold/Accumulate Unchanged

Predicted Opening Price for Compass Therapeutics, Inc. of Wednesday, May 22, 2024

Fair opening price May 22, 2024 Current price
$1.58 ( 1.31%) $1.60

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CMPX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.68 4.74 %
R2 1.64 2.43 %
R1 1.62 1.00 %
Current price: 1.60
Support S1 1.54 -3.63 %
S2 1.52 -5.06 %
S3 1.48 -7.37 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.84 15.00 %
R2 1.70 6.25 %
R1 1.62 1.25 %
Current price 1.60
Support S1 1.57 -1.88%
S2 1.54 -3.75%
S3 1.48 -7.50%

FAQ

What is the symbol for Compass Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Compass Therapeutics, Inc. is CMPX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Compass Therapeutics, Inc. Stock?
Compass Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Compass Therapeutics, Inc. Stock?
Compass Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Compass Therapeutics, Inc. Stock.

What's the current price of Compass Therapeutics, Inc. Stock?
As of the end of day on the May 21, 2024, the price of an Compass Therapeutics, Inc. (CMPX) share was $1.60.

What is the 52-week high and low for Compass Therapeutics, Inc. Stock?
The 52-week high for Compass Therapeutics, Inc. Stock is $3.61 and the 52-week low is $1.15.

What is the market capitalization of Compass Therapeutics, Inc. Stock?
As of the May 21, 2024, the market capitalization of Compass Therapeutics, Inc. is 220.142M.

When is the next earnings date for Compass Therapeutics, Inc.?
The upcoming earnings date for Compass Therapeutics, Inc. is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Compass Therapeutics, Inc.

Compass Therapeutics. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops proprietary antibody-based therapeutics to treat multiple human diseases. The company's product candidates include CTX-009, an investigational bispecific antibody, which is in Phase II clinical trial for biliary tract cancers, as well as Phase Ib clinical trial for colorectal and ovarian cancer; CTX-471, a monoclonal antibody product candidate that i... CMPX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT